中华核医学与分子影像杂志
中華覈醫學與分子影像雜誌
중화핵의학여분자영상잡지
Chinese Journal of Nuclear Medicine and Molecular Imaging
2012年
1期
46-49
,共4页
付占立%张建华%宋莉%范岩%张旭初%王荣福
付佔立%張建華%宋莉%範巖%張旭初%王榮福
부점립%장건화%송리%범암%장욱초%왕영복
肾动脉%动脉粥样硬化%血管成形术%放射性核素显像%DTPA
腎動脈%動脈粥樣硬化%血管成形術%放射性覈素顯像%DTPA
신동맥%동맥죽양경화%혈관성형술%방사성핵소현상%DTPA
Renal artery%Atherosclerosis%Angioplasty%Radionuclide imaging%DTPA
目的 探讨99Tcm-DTPA肾动态显像评价和预测经皮腔内肾动脉支架置人术(PTRAS)治疗动脉粥样硬化性肾动脉狭窄(ARAS)的疗效.方法 成功接受PTRAS治疗的单侧ARAS患者76例,分别于术前2周内和术后6个月进行99Tcm-DTPA肾动态显像,利用Gates法测定患侧GFR.根据肾动脉造影结果将狭窄程度分为轻度(50%~69%)、中度(70%~89%)、重度(≥90%)狭窄;根据术前GFR测定结果将患肾功能分为Ⅰ级(GFR≥30 ml/min)、Ⅱ级(15 ml/min≤GFR< 30 ml/min)和Ⅲ级(GFR< 15 ml/min).通过对比患者术前与术后6个月肾GFR与血压变化情况对PTRAS进行疗效判定.采用SPSS 13.0软件对数据分别进行t检验、x2检验、Fisher精确概率法检验和多元logistic回归分析.结果 术前重度狭窄患者患肾GFR低于轻中度狭窄患者[(19.48±11.56)ml/min与(26.79±15.34) ml/min,t =2.262,P=0.027].PTRAS术后血压改善者占32%( 24/75),无变化者占68%(51/75).术前患肾功能为Ⅰ、Ⅱ级患者术后高血压改善率为39.62%( 21/53),高于肾功能为Ⅲ级患者的13.64% (3/22),x2=4.825,P=0.028;多因素分析示术前患肾功能分级是影响患者术后血压改善的惟一因素(OR=0.465,P=0.032).PTRAS术后GFR改善者占22.37% (17/76),无变化者占68.42% (52/76),降低者占9.21% (7/76);在血压改善组与未改善组患者中,GFR改善的比率分别为33.33% (8/24)和17.65% (9/51),但差异无统计学意义(Fisher精确概率检验,P=0.081).结论 肾动态显像可以客观评价单侧ARAS患者PTRAS术后患肾GFR变化,并可预测术后血压改善情况.
目的 探討99Tcm-DTPA腎動態顯像評價和預測經皮腔內腎動脈支架置人術(PTRAS)治療動脈粥樣硬化性腎動脈狹窄(ARAS)的療效.方法 成功接受PTRAS治療的單側ARAS患者76例,分彆于術前2週內和術後6箇月進行99Tcm-DTPA腎動態顯像,利用Gates法測定患側GFR.根據腎動脈造影結果將狹窄程度分為輕度(50%~69%)、中度(70%~89%)、重度(≥90%)狹窄;根據術前GFR測定結果將患腎功能分為Ⅰ級(GFR≥30 ml/min)、Ⅱ級(15 ml/min≤GFR< 30 ml/min)和Ⅲ級(GFR< 15 ml/min).通過對比患者術前與術後6箇月腎GFR與血壓變化情況對PTRAS進行療效判定.採用SPSS 13.0軟件對數據分彆進行t檢驗、x2檢驗、Fisher精確概率法檢驗和多元logistic迴歸分析.結果 術前重度狹窄患者患腎GFR低于輕中度狹窄患者[(19.48±11.56)ml/min與(26.79±15.34) ml/min,t =2.262,P=0.027].PTRAS術後血壓改善者佔32%( 24/75),無變化者佔68%(51/75).術前患腎功能為Ⅰ、Ⅱ級患者術後高血壓改善率為39.62%( 21/53),高于腎功能為Ⅲ級患者的13.64% (3/22),x2=4.825,P=0.028;多因素分析示術前患腎功能分級是影響患者術後血壓改善的惟一因素(OR=0.465,P=0.032).PTRAS術後GFR改善者佔22.37% (17/76),無變化者佔68.42% (52/76),降低者佔9.21% (7/76);在血壓改善組與未改善組患者中,GFR改善的比率分彆為33.33% (8/24)和17.65% (9/51),但差異無統計學意義(Fisher精確概率檢驗,P=0.081).結論 腎動態顯像可以客觀評價單側ARAS患者PTRAS術後患腎GFR變化,併可預測術後血壓改善情況.
목적 탐토99Tcm-DTPA신동태현상평개화예측경피강내신동맥지가치인술(PTRAS)치료동맥죽양경화성신동맥협착(ARAS)적료효.방법 성공접수PTRAS치료적단측ARAS환자76례,분별우술전2주내화술후6개월진행99Tcm-DTPA신동태현상,이용Gates법측정환측GFR.근거신동맥조영결과장협착정도분위경도(50%~69%)、중도(70%~89%)、중도(≥90%)협착;근거술전GFR측정결과장환신공능분위Ⅰ급(GFR≥30 ml/min)、Ⅱ급(15 ml/min≤GFR< 30 ml/min)화Ⅲ급(GFR< 15 ml/min).통과대비환자술전여술후6개월신GFR여혈압변화정황대PTRAS진행료효판정.채용SPSS 13.0연건대수거분별진행t검험、x2검험、Fisher정학개솔법검험화다원logistic회귀분석.결과 술전중도협착환자환신GFR저우경중도협착환자[(19.48±11.56)ml/min여(26.79±15.34) ml/min,t =2.262,P=0.027].PTRAS술후혈압개선자점32%( 24/75),무변화자점68%(51/75).술전환신공능위Ⅰ、Ⅱ급환자술후고혈압개선솔위39.62%( 21/53),고우신공능위Ⅲ급환자적13.64% (3/22),x2=4.825,P=0.028;다인소분석시술전환신공능분급시영향환자술후혈압개선적유일인소(OR=0.465,P=0.032).PTRAS술후GFR개선자점22.37% (17/76),무변화자점68.42% (52/76),강저자점9.21% (7/76);재혈압개선조여미개선조환자중,GFR개선적비솔분별위33.33% (8/24)화17.65% (9/51),단차이무통계학의의(Fisher정학개솔검험,P=0.081).결론 신동태현상가이객관평개단측ARAS환자PTRAS술후환신GFR변화,병가예측술후혈압개선정황.
Objective To investigate the value of renal dynamic imaging with 99Tcm-DTPA on the evaluation and prediction of the outcome after percutaneous transluminal renal artery angioplasty and stenting (PTRAS) in patients with atherosclerotic renal artery stenosis (ARAS).Methods Seventy-six patients with unilateral ARAS underwent PTRAS successfully.All the patients received baseline renal dynamic imaging within 2 weeks before the surgery and follow-up imaging 6 months after PTRAS.GFR ( per 1.73 m2 of body surface area) of kidney with ARAS was measured with the Gates method.ARAS was classified as mild (50%-69%),moderate (70%-89%),and severe ( ≥90% ) stenosis according to the results of renoarteriography before the surgery.GFR was graded as Ⅰ ( GFR≥30 ml · min -1 ),Ⅱ ( 15 ml · min -1 ≤GFR <30 ml · min -1 ) and Ⅲ ( GFR < 15 ml · min-1 ),on the baseline dynamic imaging.Blood pressure was also measured before and after the surgery.The t test,x2 test,Fisher exact test and multiple logistic regression analysis were used for statistical analysis with SPSS 13.0.Results The baseline GFR of kidney with mild and moderate ARAS was significant higher than that with severe stenosis ( (26.79 ± 15.34) vs ( 19.48 ±11.56) ml · min - 1,t =2.262,P =0.027 ).The blood pressure was improved in 32% (24/75),and not changed in 68% (51/75) of patients.Improvement of blood pressure was observed in 39.62% (21/53) of patients with a baseline GFR≥ 15 ml · min-1,and in 13.64% (3/22) of patients with a baseline GFR <15 ml · min - 1 (x2 =4.825,P =0.028 ).Using multivariate analysis,baseline GFR ≥ 15 ml · min - 1 was the only predictor of blood pressure improvement ( OR =0.465,P =0.032 ).GFR in kidney with ARAS was improved in 22.37% ( 17/76),stable in 68.42% (52/76),and worse in 9.21% (7/76) of patients.The 33.33% (8/24) and 17.65% (9/51) of patients with and without blood pressure improvement,respectively,achieved GFR improvement.However,the difference was not statistically significant ( Fisher exact test,P =0.081 ).Conclusion Renal dynamic imaging with 99Tcm-DTPA is a useful method for the evaluation and prediction of the therapeutic effect of PTRAS in patients with ARAS.